Mature in Medical Technology

Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source

... stem cells can act as the source of tumors in mature solid tissues MEMPHIS, Tenn., Dec. 17 ... cells that can renew themselves and give rise to mature differentiated cells that compose the range of ... stem cells arise from normal stem cells or more mature cancer cells that somehow reacquire the ...

Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma

... - Phase II Trial Shows Increase in mature Dendritic Cells - WAYNE, N.J., June 30 ... overall survival of 65 months and increased mature dendritic cells in high-risk melanoma patients. ... study. However, the ability of Leukine to induce mature dendritic cells appeared to be confined to those ...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... the first demonstration of transplanted human neurons synapsing, or making mature structural connections, with the rat motor neurons, something which has ... "This study shows, at the ultra-structural level, that these cells make mature connections with host motor neurons in the spinal cord," said Dr. Vassilis ...

Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease

... cells, multiply them in vitro and ultimately differentiate them to produce mature neurons before they are reintroduced into the brain's basal ganglia. This ... of several steps in human neurogenesis to regenerate millions of mature neurons characterized before transplantation. These steps are essential to ...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

... or blood-forming, stem cells and have the potential to become mature red blood cells, white blood cells, or platelets. Myeloproliferative ... disorders. These JAK2 and MP L defects cause the overproduction of mature malignant blood cells, but multiple lines of evidence suggest that these ...

St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory

... interneurons. This disproves the scientific principle that fully formed, mature nerves cannot multiply like young, immature cells, Dyer said. Human ... past 100 years, it's been ingrained among scientists that differentiated mature nerves are so elaborate that they can't divide, and if they try to divide, ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... enrollment in a Phase 3 study in heterozygous FH patients with coronary artery disease. Isis' partnered pipeline continues to mature as antisense drugs that Isis' satellite companies are developing advance in clinical development. Altair reported a Phase 1 study that ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infection. In lupus and certain other autoimmune ...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

... toxicity of proteins in Alzheimer's disease and other neurodegenerative diseases. These assays emphasize phenotypic or functional responses of mature primary neurons to the toxic proteins. Cognition's proprietary chemistry platform converts natural products into low molecular weight chemically ...

MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes

... destruction of the insulin-producing beta cells of the islets of the pancreas. Teplizumab binds to an epitope of the CD3-epsilon chain expressed on mature T cells and by doing so, may modulate the immunologic response that is a key component of the disease. If teplizumab is effective and has the ability ...

FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)

... therapies. GSK's BioPharm R&D division has a rich early pipeline based on cutting edge molecular biology and genetic technology and a mature late-stage portfolio that will provide important medicines to oncology. About Genmab A/S Genmab is a leading international biotechnology ...

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

... of inflammatory cytokines and chemokines. PGN632 also induced an increase in the expression of cell-surface molecules that are indicative of mature dendritic cells and that assist in antigen presentation functions, as well as in stimulating T-cell proliferation. "These results demonstrate ...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

... of inflammatory cytokines and chemokines. PGN632 also induced an increase in the expression of cell-surface molecules that are indicative of mature dendritic cells and that assist in antigen presentation functions, as well as in stimulating T-cell proliferation. Dr. Xianming Huang, assistant ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... and found that leukemia cells from patients with IKAROS alterations expressed primitive, stem cell-like genes, suggesting that the cells are less mature and possibly more resistant to the effects of drugs used to treat ALL. "These findings show how detailed analysis of leukemic cells using ...

Sosei Confirms the Safety of SD118 in Two Phase I Trials

... to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain. During 2008, the Company reported success in a Phase II trial for NSL-101. The ...

Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

... data with a median follow-up of approximately 30 months for both arms. OncoGenex indicates that additional survival updates will be needed before mature median survival for the OGX-011 arm can be reported. Based on the current results, OncoGenex has calculated that the final median survival for ...

Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity

... Biology. Differentiation is the process by which genetic activity causes an immature cell type to acquire specific characteristics of a particular mature adult cell type. "In the last few years, some discoveries have challenged the long-standing belief that cell differentiation is an ...

St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse

... According to the researchers, the relapse-related genetic changes commonly disrupted the machinery by which white blood cells called B cells mature and proliferate. Importantly, the relapse-related genetic changes only infrequently involved genes directly regulating the responsiveness to ...

Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting

... to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain. During 2008, the Company reported success in a Phase II trial for NSL-101. The ...

BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

... Significant Improved Overall Survival. MOUNTAIN VIEW, California, October 7 /PRNewswire/ -- BN ImmunoTherapeutics has now evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership ...

Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

... Randomized Placebo-Controlled Phase II Study Shows Statistically Significant Improved Overall Survival Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership ...

Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial

... stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infection. In lupus and certain other autoimmune ...

Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation

... synapses and may reduce beta amyloid. "While researchers continue to investigate amyloid as a target for Alzheimer's therapies - it is the most mature theory being pursued - we must also examine other potential avenues given the urgency of conquering this disease," said Samuel Gandy, MD, Ph.D., ...

ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)

... for the treatment of first-line metastatic colorectal cancer. The primary endpoint of the study was progression-free survival, which is expected to mature and be reported by the Company along with safety data later this year. Data from the 85 patients treated in the study demonstrated a ...

ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations

... companies, and community oncology practices. (Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO ) "Our data warehouse is now mature enough to support longitudinal or cross- sectional analyses comparing practice patterns, toxicity, and outcomes in large groups of patients ...

Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus

... stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infection. In lupus and certain other autoimmune ...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

... Dr. Timothy Shannon, President and Chief Executive Officer of CuraGen Corporation. "This trial is enrolling well, and we expect the data to quickly mature allowing us to provide further updates from the study later in the second half of this year." Dr. Ronit Simantov, Vice President and Chief Medical ...

TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)

... dendritic cells, CD8+ killer T cells, and CD138+ plasma B cells, with lesser amounts of CD68+ macrophages and CD20+ B cells, suggesting a relatively mature or advanced immune response. Taken together, this landmark study demonstrates (1) that the functionality of the gene delivery platform is profound; ...

Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials

... stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infections. In lupus and certain other autoimmune ...

Neuroscientists Offer Hope for Breast Cancer Patients Suffering From 'Chemobrain'

... program consists of a series of 6 specially designed exercises that have been shown in published studies to improve memory and speed of processing in mature adults. Study results showed that participants had statistically significant improvements in cognitive function, stress levels and ...

More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk

... Paper -- Medication -Related Problems in Older Adults -- The Silent Epidemic CHEC.org (Consumer Health Education Center) -- Drug Facts for mature Americans Col N, Fanale JE, Kronholm P. -- The role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the ...

Northwestern Memorial Transplant Program Initiates New Study

... of the kidney transplant. By transplanting these cells from the kidney donor into the recipient, the study seeks to prove that the stem cells will mature in the recipient's body and will allow his immune system to accept the new organ as his own. For the kidney donor, the laparoscopic surgery ...

Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus

... stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infection. In lupus, rheumatoid arthritis and certain ...

IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients

... regulatory and manufacturing activities for UVIDEM. Sanofi-aventis has worldwide marketing rights to UVIDEM in melanoma. UVIDEM consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. UVIDEM is produced in IDM Pharma cGMP manufacturing facilities in Irvine, ...

AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer

... demonstrated that the absence of the Id genes in animals results in a highly significant inhibition of tumor growth and a reduction in the size of mature tumors. The research of Dr. Benezra on the role of the Id genes in tumor formation has been widely recognized for its important therapeutic ...

Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

... with oral anticoagulants. Pregnancy and Lactation Avoid in pregnancy and do not use in breast-feeding women. Pemetrexed can be genotoxic; sexually mature males are advised not to father a child during treatment and up to 6 months thereafter. Owing to the possibility of irreversible infertility, men are ...

MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus

... destruction of the insulin-producing beta cells of the islets of the pancreas. Teplizumab binds to an epitope of the CD3-epsilon chain expressed on mature T cells and by doing so, may modulate the immunologic response that causes disease. About Type 1 Diabetes Type 1 diabetes is an autoimmune disease ...

Researchers at Cleveland Clinic Identify Site of 'Dysfunction' in HDL, Carrier of Good Cholesterol

... HDL is modified by myeloperoxidase (MPO), an enzyme present in white blood cells and found in atherosclerotic plaque. This inhibits HDL's ability to mature and effectively carry cholesterol cargo from cells of the artery wall. In their paper, the researchers describe the HDL as having a "solar ...

Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function

... are found in the adult bone marrow and have the potential to develop into mature heart cells and new blood vessels. The MSC cells are derived from ... Adult stem cells are designed by nature to perform tissue repair in a mature adult. It is believed that these cells can be used in patients unrelated ...